You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海泰新光(688677.SH):今年關節鏡、宮腔鏡等其他科室的產品也在進行註冊,預計下半年都能獲得註冊並上市銷售
格隆匯 05-09 18:58

格隆匯5月9日丨海泰新光(688677.SH)於2023年4月接受機構調研,就“去年自主品牌銷售情況,今年整機銷售的預期,後期還會推出不同科室的產品嗎?”,公司表示,在國內市場,公司去年內窺鏡產品的增長是比較不錯的,其中增長最多的是腹腔鏡產品。腹腔鏡的銷售我們是採用兩種銷售模式,一種是銷售到下游生產廠商,由下游廠商集成內窺鏡系統進行銷售。另一種是由經銷商直接將公司的腹腔鏡銷售到醫院。公司於去年5月份將整機系統投放市場進行試用,第四季度已經實現了一些銷售,今年一季度也延續了這樣的發展態勢。今年,公司的關節鏡、宮腔鏡等其他科室的產品也在進行註冊,預計下半年都能獲得註冊並上市銷售,同時公司也在圍繞泌尿科、神經外科、耳鼻喉科等科室應用,不斷開發新的產品。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account